시장보고서
상품코드
1485240

전자처방전 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 서비스별, 분야별, 전문 분야별, 제공 모드별, 물질별, 지역별, 경쟁사별(2019-2029년)

E-Prescribing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Solutions ), Services, By Specialties, By Delivery Mode, By Substances, By Region and Competition, 2019-2029F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 182 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전자처방전 세계 시장 규모는 2023년 25억 2,000만 달러에 달했으며, 예측 기간 동안 2029년까지 연평균 8.30%의 꾸준한 성장세를 보일 것으로 예상됩니다.

날로 발전하는 의료 분야에서 기술의 발전은 의료 종사자들이 환자 치료를 제공하는 방식을 계속 변화시키고 있습니다. 이러한 기술 혁신 중 하나는 최근 몇 년동안 큰 지지를 받고 있는 전자처방전입니다. 전 세계 전자처방전 시장은 의료진, 약국, 환자들이 그 이점을 점점 더 많이 인식함에 따라 크게 성장하고 있습니다. 전자처방전은 의료 서비스 제공업체가 처방전을 전자적으로 작성하여 약국에 전송할 수 있는 디지털 솔루션입니다. 기존의 수기 및 인쇄된 종이 처방전을 대체하여 보다 효율적이고 정확한 약물 관리를 가능하게 합니다. 전자처방전에는 처방전 작성, 실시간 약력 조회, 투약 알림, 전자건강기록(EHR) 연결 등 다양한 구성요소가 포함되어 있습니다.

시장 개요
예측 기간 2025-2029년
시장 규모 : 2023년 25억 2,000만 달러
시장 규모 : 2029년 40억 8,000만 달러
CAGR : 2024-2029년 8.30%
급성장 부문 솔루션
최대 시장 북미

전자처방전은 읽기 어려운 필기체, 잘못된 복용량 등 투약 오류의 가능성을 줄여 환자의 안전을 향상시킵니다. 수기 입력의 번거로움을 없애고 의료진의 관리 부담을 줄여 처방 프로세스를 간소화합니다. 전자처방전 시스템에는 환자가 복약 알림을 받거나 관련 정보에 접근할 수 있는 기능이 탑재되어 있어 복약 순응도를 높이는 데 도움이 됩니다. 전자처방전 솔루션은 전자 의료 기록과 통합되어 치료 시점에 종합적인 환자 정보를 제공합니다. 각국 정부와 규제 기관은 의료 서비스 품질 향상과 비용 절감을 위해 전자처방전 도입을 장려하고 있습니다.

주요 시장 성장 촉진요인

정부의 이니셔티브와 규제 증가

효율성 및 편의성 향상

주요 시장 과제

도입의 장벽

데이터의 프라이버시 및 보안

투약 오류 및 의사결정 지원

주요 시장 동향

기술의 발전

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 전자 처방 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별(솔루션(통합 솔루션, 스탠드얼론 솔루션), 서비스(지원, 구현, 트레이닝, 네트워크))
    • 전문 분야별(종양학, 스포츠 의학, 신경학, 심장병학, 기타)
    • 제공 모드별(Web/클라우드 기반, 온프레미스)
    • 물질별(규제 물질, 비규제 물질)
    • 지역별
    • 기업별(2023년)
  • 시장 맵
    • 제품별
    • 전문 분야별
    • 제공 모드별
    • 물질별
    • 지역별

제5장 아시아태평양의 전자 처방 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 전문 분야별
    • 제공 모드별
    • 물질별
    • 국가별
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 호주
    • 일본
    • 한국

제6장 유럽의 전자 처방 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 전문 분야별
    • 제공 모드별
    • 물질별
    • 국가별
  • 유럽 : 국가별 분석
    • 프랑스
    • 독일
    • 스페인
    • 이탈리아
    • 영국

제7장 북미의 전자 처방 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 전문 분야별
    • 제공 모드별
    • 물질별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 멕시코
    • 캐나다

제8장 남미의 전자 처방 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 전문 분야별
    • 제공 모드별
    • 물질별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제9장 중동 및 아프리카의 전자 처방 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 전문 분야별
    • 제공 모드별
    • 물질별
    • 국가별
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)

제10장 시장 역학

  • 성장 촉진요인
  • 과제

제11장 시장 동향과 발전

  • 최근 동향
  • 제품 출시
  • 인수합병(M&A)

제12장 세계의 전자 처방 시장 : SWOT 분석

제13장 Porter의 Five Forces 분석

  • 업계내 경쟁
  • 신규 참여 가능성
  • 공급업체의 힘
  • 고객의 힘
  • 대체품의 위협

제14장 경쟁 구도

  • Oracle Corp.
  • Veradigm LLC
  • Epic Systems Corporation
  • Athenahealth, Inc.
  • NextGen Healthcare, Inc.
  • McKesson Corporation
  • Surescripts, LLC
  • Change Healthcare LLC
  • Practice Fusion, Inc.
  • Networking Technology, Inc.

제15장 전략적 제안

제16장 리서치사에 대해 & 면책사항

LSH 24.06.04

Global E-Prescribing Market was valued at USD 2.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 8.30% through 2029. In the ever-evolving landscape of healthcare, technological advancements continue to shape the way medical professionals deliver patient care. One such innovation that has gained significant traction in recent years is electronic prescribing, or e-prescribing. The Global E-Prescribing Market has been experiencing substantial growth as healthcare providers, pharmacies, and patients increasingly recognize its benefits. Electronic prescribing, commonly referred to as e-prescribing, is a digital solution that allows healthcare providers to generate and transmit prescription orders electronically to pharmacies. It replaces traditional handwritten or printed paper prescriptions, offering a more efficient and accurate method for medication management. E-prescribing encompasses various components, including the creation of prescriptions, real-time medication history access, medication alerts, and connectivity to electronic health records (EHRs).

Market Overview
Forecast Period2025-2029
Market Size 2023USD 2.52 Billion
Market Size 2029USD 4.08 Billion
CAGR 2024-20298.30%
Fastest Growing SegmentSolutions
Largest MarketNorth America

E-prescribing reduces the potential for medication errors, such as illegible handwriting and incorrect dosages, resulting in improved patient safety. It streamlines the prescription process by eliminating the need for manual entry and reducing administrative burdens on healthcare professionals. E-prescribing systems often come with features that enable patients to receive medication reminders and access relevant information, contributing to improved adherence. E-prescribing solutions are increasingly integrated with electronic health records, providing comprehensive patient information at the point of care. Governments and regulatory bodies in many countries have encouraged the adoption of e-prescribing to enhance healthcare quality and reduce costs.

Key Market Drivers

Increasing Government Initiatives and Regulations

The global healthcare landscape is evolving at a rapid pace, with technological advancements playing a pivotal role in transforming the way medical services are delivered. One such technological revolution in healthcare is the adoption of electronic prescribing, commonly known as e-prescribing. E-prescribing is a digital solution that streamlines the prescription process, ensuring accuracy, efficiency, and patient safety. In recent years, the global e-prescribing market has witnessed substantial growth, largely fueled by increasing government initiatives and regulations aimed at enhancing healthcare quality and reducing medication errors.

The growth of the global e-prescribing market can be primarily attributed to the increasing support and guidance from governments and regulatory bodies. These initiatives aim to address various issues within the healthcare system, such as patient safety, healthcare quality, and cost containment. In the United States, the Centers for Medicare and Medicaid Services (CMS) introduced the Electronic Health Record (EHR) Incentive Program, commonly referred to as "Meaningful Use." This program provides financial incentives to healthcare providers who adopt and demonstrate the meaningful use of EHRs, including e-prescribing.

Various governments around the world have launched healthcare information technology (IT) initiatives to encourage the implementation of EHRs and e-prescribing systems, often providing financial incentives to healthcare organizations that comply. Regulatory bodies like The Joint Commission in the United States and similar organizations globally have recognized e-prescribing as a means to enhance patient safety, thereby encouraging its adoption by healthcare facilities. Governments have played a role in setting standards and promoting interoperability between healthcare systems, ensuring seamless data exchange between different stakeholders in the healthcare ecosystem.

Increased Efficiency and Convenience

One of the primary drivers of the global e-prescribing market is the significant improvement in efficiency it offers. Healthcare providers, including physicians, nurse practitioners, and other prescribers, can easily access patients' medical histories, insurance information, and preferred pharmacies. This information allows them to make informed decisions quickly and prescribe the most suitable medication, eliminating errors and ensuring patient safety. E-prescribing enables real-time communication with pharmacies, reducing waiting times for patients and enhancing overall healthcare delivery. E-prescribing plays a vital role in enhancing patient safety by reducing medication errors. The digitization of prescriptions minimizes the chances of misinterpretation or illegible handwriting, which can lead to adverse drug events. With e-prescribing, drug-drug interaction alerts and dosage recommendations are readily available, assisting prescribers in making informed decisions. This leads to a safer and more effective medication management process for patients.

The adoption of e-prescribing systems has streamlined healthcare workflows for both providers and pharmacies. Prescribers can quickly and accurately send prescriptions to pharmacies, eliminating the need for patients to carry physical prescriptions. Pharmacists, in turn, can efficiently process electronic prescriptions, reducing wait times and enhancing customer satisfaction. These streamlined processes have a significant impact on patient care and overall healthcare system efficiency.

Key Market Challenges

Implementation Barriers

One of the primary challenges faced by the e-prescribing market is the resistance to implementation. Transitioning from paper-based prescription systems to electronic prescribing requires significant investment in both technology and training. Healthcare providers, especially in smaller practices and rural areas, may find it challenging to adapt to new systems, which can lead to slower adoption rates. Moreover, interoperability issues between various electronic health record (EHR) systems and pharmacy software can hinder seamless information exchange. Ensuring that these systems can communicate effectively is crucial for the success of e-prescribing.

Data Privacy and Security

The healthcare industry, including e-prescribing, deals with sensitive patient information. The need to protect patient data from security breaches and unauthorized access is paramount. Healthcare providers and technology companies must invest in robust cybersecurity measures to safeguard electronic health records and prescription data. Compliance with stringent data protection regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States, adds complexity to the e-prescribing landscape.

Medication Errors and Decision Support

While e-prescribing can reduce some medication errors associated with illegible handwriting, it introduces new challenges. Decision support tools embedded in e-prescribing systems may generate alerts and suggestions for healthcare providers, but these alerts can sometimes be overwhelming and lead to alert fatigue. Striking the right balance between providing useful guidance and avoiding excessive interruptions in the workflow of healthcare professionals is a significant challenge.

Key Market Trends

Technological Advancements

The global healthcare industry is undergoing a profound transformation, largely driven by the increasing adoption of advanced technologies. One of the significant technological advancements revolutionizing healthcare is e-prescribing, a practice that allows healthcare providers to electronically generate and send prescriptions to pharmacies. E-prescribing has come a long way since its inception in the early 2000s. What started as a convenient alternative to handwritten prescriptions has evolved into a sophisticated system that leverages the power of technology to improve the entire medication management process. In the early days, e-prescribing systems were relatively basic, primarily focused on eliminating errors caused by illegible handwriting. However, today's e-prescribing solutions are significantly more advanced and provide a multitude of benefits for both healthcare providers and patients.

One of the key technological advancements driving the growth of the e-prescribing market is improved interoperability. Modern e-prescribing systems can seamlessly integrate with electronic health records (EHR) and other healthcare information systems. This integration allows healthcare providers to access a patient's complete medical history, drug allergies, and medication records, ensuring that prescriptions are safer and more accurate. Sophisticated decision support tools integrated into e-prescribing systems assist healthcare providers in making more informed decisions. These tools provide real-time drug interaction alerts, dosage recommendations, and generic drug alternatives, thereby enhancing patient safety and helping to reduce medication errors.

The advent of mobile and cloud-based e-prescribing solutions has made it easier for healthcare providers to create and transmit electronic prescriptions from virtually anywhere. This flexibility not only improves efficiency but also allows for more convenient and timely patient care. The rise of telemedicine has further fueled the adoption of e-prescribing. Telehealth consultations often culminate in the need for a prescription, which can be efficiently generated and transmitted electronically through the same platform, enhancing the patient experience. E-prescribing systems have significantly improved in terms of security features. Encryptions, user authentication, and audit trails ensure that patient data remains secure and compliant with privacy regulations. This reassures both healthcare providers and patients.

Segmental Insights

Product Insights

Based on product, solutions emerged as the fastest growing segment in the global market for e-prescribing in 2023. E-prescribing significantly reduces the chances of prescription errors. The ability to access a patient's complete medical history and drug allergies in real-time allows healthcare providers to make informed decisions, leading to safer patient care. It minimizes the risk of misinterpretation of handwritten prescriptions. E-prescribing systems offer automated reminders and alerts for patients, ensuring that they adhere to their prescribed medication regimens. This feature contributes to better health outcomes and reduces the likelihood of hospital readmissions.

Specialties Insights

Based on specialties, the sports medicine segment is projected to experience rapid growth during the forecast period. Sports medicine is a specialized branch of healthcare that focuses on the prevention, diagnosis, treatment, and rehabilitation of injuries and conditions related to physical activity and sports. It encompasses a wide range of medical disciplines, including orthopedics, physical therapy, sports science, nutrition, and more. As the popularity of sports and physical fitness continues to rise, the demand for sports medicine services has grown significantly.

Athletes frequently encounter injuries that require specialized treatments and medications. E-prescribing simplifies the process of prescribing medications and rehabilitation equipment, allowing sports medicine professionals to quickly and accurately provide the necessary care. This not only accelerates the recovery process but also reduces the risk of medication errors. In the high-pressure world of sports, it is crucial to ensure that athletes receive the right medication at the right time. E-prescribing systems come with safety features, such as drug interaction checks and allergy alerts, that help sports medicine practitioners avoid potentially dangerous medication combinations. E-prescribing promotes better communication between sports medicine practitioners, athletes, and pharmacists. When a prescription is electronically transmitted, the pharmacist can easily access detailed information, enabling them to prepare the medication and equipment more efficiently. This seamless collaboration ensures that athletes receive the most effective treatment.

Regional Insights

Based on region, North America emerged as the dominant region in the Global E-Prescribing Market in 2023, holding the largest market share in terms of value. One of the primary reasons for North America's prominence in the e-prescribing market is the robust regulatory support and framework in place. The United States, in particular, has played a pivotal role in shaping e-prescribing guidelines and standards. The Drug Enforcement Administration (DEA) established the Electronic Prescriptions for Controlled Substances (EPCS) rule, allowing the electronic prescribing of controlled substances, which was a significant milestone in advancing e-prescribing technology. E-prescribing systems significantly enhance patient safety by reducing medication errors, which are a significant concern in healthcare. These systems allow healthcare providers to access patients' medication histories, check for potential drug interactions, and provide accurate dosage information, leading to a decrease in adverse drug events. Patients can also receive their prescriptions directly at the pharmacy, eliminating the need for paper prescriptions that can be lost or misinterpreted. This emphasis on patient safety has been a driving factor behind the adoption of e-prescribing in North America.

Key Market Players

Oracle Corp.

Veradigm LLC

Epic Systems Corporation

Athenahealth, Inc.

NextGen Healthcare, Inc.

McKesson Corporation

Surescripts, LLC

Change Healthcare LLC

Practice Fusion, Inc.

Networking Technology, Inc.

Report Scope:

In this report, the Global E-Prescribing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

E-Prescribing Market, By Product:

    Solutions Services

E-Prescribing Market, By Specialties:

    Oncology Sports Medicine Neurology Cardiology Others

E-Prescribing Market, By Delivery Mode:

    Web/Cloud Based On Premise

E-Prescribing Market, By Substances:

    Controlled Substances Non-controlled Substances

E-Prescribing Market, By Region:

    North America

United States

Canada

Mexico

    Europe

France

United Kingdom

Italy

Germany

Spain

    Asia Pacific

China

India

Japan

Australia

South Korea

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global E-Prescribing Market.

Available Customizations:

Global E-Prescribing Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global E-Prescribing Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product (Solutions (Integrated Solutions, Standalone Solutions), Services(Support, Implementation, Training, Network)
    • 4.2.2. By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others)
    • 4.2.3. By Delivery Mode (Web/Cloud Based, On Premise)
    • 4.2.4. By Substances (Controlled Substances, Non-controlled Substances)
    • 4.2.5. By Region
    • 4.2.6. By Company (2023)
  • 4.3. Market Map
    • 4.3.1. By Product
    • 4.3.2. By Specialties
    • 4.3.3. By Delivery Mode
    • 4.3.4. By Substances
    • 4.3.5. By Region

5. Asia Pacific E-Prescribing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Specialties
    • 5.2.3. By Delivery Mode
    • 5.2.4. By Substances
    • 5.2.5. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China E-Prescribing Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Product
        • 5.3.1.2.2. By Specialties
        • 5.3.1.2.3. By Delivery Mode
        • 5.3.1.2.4. By Substances
    • 5.3.2. India E-Prescribing Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Product
        • 5.3.2.2.2. By Specialties
        • 5.3.2.2.3. By Delivery Mode
        • 5.3.2.2.4. By Substances
    • 5.3.3. Australia E-Prescribing Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Product
        • 5.3.3.2.2. By Specialties
        • 5.3.3.2.3. By Delivery Mode
        • 5.3.3.2.4. By Substances
    • 5.3.4. Japan E-Prescribing Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Product
        • 5.3.4.2.2. By Specialties
        • 5.3.4.2.3. By Delivery Mode
        • 5.3.4.2.4. By Substances
    • 5.3.5. South Korea E-Prescribing Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Product
        • 5.3.5.2.2. By Specialties
        • 5.3.5.2.3. By Delivery Mode
        • 5.3.5.2.4. By Substances

6. Europe E-Prescribing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Specialties
    • 6.2.3. By Delivery Mode
    • 6.2.4. By Substances
    • 6.2.5. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France E-Prescribing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Specialties
        • 6.3.1.2.3. By Delivery Mode
        • 6.3.1.2.4. By Substances
    • 6.3.2. Germany E-Prescribing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Specialties
        • 6.3.2.2.3. By Delivery Mode
        • 6.3.2.2.4. By Substances
    • 6.3.3. Spain E-Prescribing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Specialties
        • 6.3.3.2.3. By Delivery Mode
        • 6.3.3.2.4. By Substances
    • 6.3.4. Italy E-Prescribing Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product
        • 6.3.4.2.2. By Specialties
        • 6.3.4.2.3. By Delivery Mode
        • 6.3.4.2.4. By Substances
    • 6.3.5. United Kingdom E-Prescribing Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product
        • 6.3.5.2.2. By Specialties
        • 6.3.5.2.3. By Delivery Mode
        • 6.3.5.2.4. By Substances

7. North America E-Prescribing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Specialties
    • 7.2.3. By Delivery Mode
    • 7.2.4. By Substances
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States E-Prescribing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Specialties
        • 7.3.1.2.3. By Delivery Mode
        • 7.3.1.2.4. By Substances
    • 7.3.2. Mexico E-Prescribing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Specialties
        • 7.3.2.2.3. By Delivery Mode
        • 7.3.2.2.4. By Substances
    • 7.3.3. Canada E-Prescribing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Specialties
        • 7.3.3.2.3. By Delivery Mode
        • 7.3.3.2.4. By Substances

8. South America E-Prescribing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Specialties
    • 8.2.3. By Delivery Mode
    • 8.2.4. By Substances
    • 8.2.5. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil E-Prescribing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Specialties
        • 8.3.1.2.3. By Delivery Mode
        • 8.3.1.2.4. By Substances
    • 8.3.2. Argentina E-Prescribing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Specialties
        • 8.3.2.2.3. By Delivery Mode
        • 8.3.2.2.4. By Substances
    • 8.3.3. Colombia E-Prescribing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Specialties
        • 8.3.3.2.3. By Delivery Mode
        • 8.3.3.2.4. By Substances

9. Middle East and Africa E-Prescribing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Specialties
    • 9.2.3. By Delivery Mode
    • 9.2.4. By Substances
    • 9.2.5. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa E-Prescribing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Specialties
        • 9.3.1.2.3. By Delivery Mode
        • 9.3.1.2.4. By Substances
    • 9.3.2. Saudi Arabia E-Prescribing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Specialties
        • 9.3.2.2.3. By Delivery Mode
        • 9.3.2.2.4. By Substances
    • 9.3.3. UAE E-Prescribing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Specialties
        • 9.3.3.2.3. By Delivery Mode
        • 9.3.3.2.4. By Substances

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global E-Prescribing Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Oracle Corp.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Product & Services
    • 14.1.4. Financials (In case of listed)
    • 14.1.5. Recent Developments
    • 14.1.6. SWOT Analysis
  • 14.2. Veradigm LLC
  • 14.3. Epic Systems Corporation
  • 14.4. Athenahealth, Inc.
  • 14.5. NextGen Healthcare, Inc.
  • 14.6. McKesson Corporation
  • 14.7. Surescripts, LLC
  • 14.8. Change Healthcare LLC
  • 14.9. Practice Fusion, Inc.
  • 14.10.Networking Technology, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제